Nirmal Mulye

Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY.

Nostrum Pharmaceuticals LLC engages in the formulation and commercialization of specialty pharmaceutical products and drugs. The firm also provides research and development services. The company was founded by Nirmal Mulye in 1995 and is headquartered in Somerset, NJ.

Merlin MD Pte Ltd. develops life-saving and life-enhancing devices for the treatment of cerebral aneurysms. The company was founded on July 1, 2002 and is headquartered in Singapore.

Nostrum Laboratories, Inc. manufactures and markets pharmaceutical products. It offers Sucralfate tablet, Theophylline ER tablet, piroxicam capsules USP and Carbamazepine ER capsules. The company was founded in 2006 and is headquartered in Kansas City, MO.